INTERPACE BIOSCIENCES, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Interpace Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Interpace Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $1.91M.
  • Interpace Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $6.35M, a 311% increase year-over-year.
  • Interpace Biosciences, Inc. annual Operating Income (Loss) for 2023 was $2.8M.
  • Interpace Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$3.62M, a 42.9% increase from 2021.
  • Interpace Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$6.34M, a 75.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.35M $1.91M +$1.92M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $4.43M $2.26M +$1.43M +171% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3M $874K +$199K +29.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.8M $1.31M +$1.26M +2331% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.55M -$16K +$764K +97.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $781K $832K +$2.75M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$1.97M $675K +$1.65M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$3.62M $54K -$2.16M -97.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$1.46M -$780K +$1.05M +57.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$2.51M -$1.91M +$992K +34.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$3.5M -$977K +$2.84M +74.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$6.34M $2.21M +$10.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$16.5M -$1.83M +$4.18M +69.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$20.7M -$2.91M +$2.87M +49.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$23.5M -$3.82M +$2.54M +39.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$26.1M -$7.94M +$2.84M +26.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$28.9M -$6.01M +$1.13M +15.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$30M -$5.77M -$425K -7.95% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$29.6M -$6.35M -$3.17M -99.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$26.4M -$10.8M -$5.75M -115% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 -$20.7M -$7.13M -$4.67M -189% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-20
Q2 2019 -$16M -$5.35M -$3.45M -182% Apr 1, 2019 Jun 30, 2019 10-Q/A 2021-01-19
Q1 2019 -$12.6M -$3.18M +$65K +2% Jan 1, 2019 Mar 31, 2019 10-Q/A 2021-01-19
Q4 2018 -$12.6M -$5.02M -$1.72M -52.3% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
Q3 2018 -$10.9M -$2.47M +$630K +20.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$11.5M -$1.9M +$1.7M +47.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$13.2M -$3.25M -$6.95M -188% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$6.29M -$3.3M -$10M -149% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 $3.75M -$3.1M +$3.39M +52.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $352K -$3.6M -$704K -24.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.06M $3.7M +$7.5M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$6.44M $6.74M +$26.7M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 -$33.1M -$6.49M +$165K +2.48% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$33.3M -$2.89M +$4.82M +62.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$38.1M -$3.8M +$2.32M +37.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$40.4M -$19.9M -$6.77M -51.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$33.6M -$6.65M -$3.45M -108% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-17
Q2 2015 -$30.2M -$7.71M -$6.65M -626% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$23.5M -$6.12M -$5.71M -1379% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$17.8M -$13.1M -$12.4M -1562% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$5.47M -$3.2M -$1.15M -56% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$4.32M -$1.06M -$215K -25.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$4.1M -$414K -$2.67M -118% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$1.44M -$791K +$23.1M +96.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-05
Q3 2013 -$24.6M -$2.05M -$1.3M -171% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$23.3M -$847K -$531K -168% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$22.8M $2.25M +$2.47M Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-08-19
Q4 2012 -$25.2M -$23.9M -$21.5M -882% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-06
Q3 2012 -$3.73M -$756K -$951K -488% Jul 1, 2012 Sep 30, 2012 10-Q/A 2014-09-30
Q2 2012 -$2.78M -$316K +$755K +70.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 -$3.53M -$221K +$1.17M +84.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$4.7M -$2.44M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 $195K -$225K -53.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 -$1.07M -$435K -68.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.39M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $420K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$636K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.